Jerome Levine

1.8k total citations
43 papers, 1.2k citations indexed

About

Jerome Levine is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jerome Levine has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Psychiatry and Mental health, 14 papers in Clinical Psychology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jerome Levine's work include Schizophrenia research and treatment (20 papers), Pharmaceutical studies and practices (11 papers) and Psychedelics and Drug Studies (8 papers). Jerome Levine is often cited by papers focused on Schizophrenia research and treatment (20 papers), Pharmaceutical studies and practices (11 papers) and Psychedelics and Drug Studies (8 papers). Jerome Levine collaborates with scholars based in United States, Czechia and Italy. Jerome Levine's co-authors include Ari Jaffe, Leslie Citrome, Arnold M. Ludwig, Mitchell B. Balter, Dean I. Manheimer, Baerbel Allingham, Robert F. Prien, Nina R. Schooler, J. E. M. Robinson and Jonathan Cole and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Jerome Levine

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerome Levine United States 19 701 370 170 149 110 43 1.2k
Cesario Bellantuono Italy 25 591 0.8× 766 2.1× 172 1.0× 190 1.3× 206 1.9× 97 2.1k
R R Fieve United States 26 1.1k 1.6× 456 1.2× 129 0.8× 413 2.8× 129 1.2× 63 1.8k
Michael D. Jibson United States 17 944 1.3× 280 0.8× 47 0.3× 169 1.1× 118 1.1× 57 1.5k
Albert A. Kurland United States 23 490 0.7× 536 1.4× 84 0.5× 224 1.5× 126 1.1× 100 1.4k
Dan Zimbroff United States 12 890 1.3× 317 0.9× 117 0.7× 266 1.8× 73 0.7× 21 1.3k
Thomas Shiovitz United States 16 554 0.8× 179 0.5× 96 0.6× 303 2.0× 77 0.7× 28 1.2k
Gilbert Honigfeld United States 17 1.5k 2.1× 426 1.2× 140 0.8× 197 1.3× 197 1.8× 47 2.1k
Joseph DeVeaugh-Geiss United States 16 799 1.1× 661 1.8× 205 1.2× 156 1.0× 262 2.4× 32 1.6k
K. Behnke Denmark 19 983 1.4× 334 0.9× 130 0.8× 620 4.2× 116 1.1× 33 1.6k
Glen L. Stimmel United States 20 572 0.8× 145 0.4× 136 0.8× 252 1.7× 49 0.4× 44 1.2k

Countries citing papers authored by Jerome Levine

Since Specialization
Citations

This map shows the geographic impact of Jerome Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome Levine more than expected).

Fields of papers citing papers by Jerome Levine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome Levine. The network helps show where Jerome Levine may publish in the future.

Co-authorship network of co-authors of Jerome Levine

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome Levine. A scholar is included among the top collaborators of Jerome Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome Levine. Jerome Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Citrome, Leslie, Ari Jaffe, & Jerome Levine. (2010). Depot Antipsychotic Use in New York State Hospitals, 1994 to 2009. Psychiatric Services. 61(1). 1 indexed citations
2.
Citrome, Leslie, Ari Jaffe, & Jerome Levine. (2010). Datapoints: Depot Antipsychotic Use in New York State Hospitals, 1994 to 2009. Psychiatric Services. 61(1). 9–9. 4 indexed citations
3.
Citrome, Leslie, Ari Jaffe, & Jerome Levine. (2010). Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities. Schizophrenia Research. 119(1-3). 153–159. 10 indexed citations
4.
Citrome, Leslie, Ari Jaffe, & Jerome Levine. (2009). How Dosing of Ziprasidone in a State Hospital System Differs From Product Labeling. The Journal of Clinical Psychiatry. 70(7). 975–982. 20 indexed citations
5.
Citrome, Leslie, et al.. (2008). Datapoints: Did CATIE Influence Antipsychotic Use?. Psychiatric Services. 59(5). 476–476. 4 indexed citations
6.
Citrome, Leslie, Ari Jaffe, & Jerome Levine. (2007). Datapoints: The Ups and Downs of Dosing Second-Generation Antipsychotics. Psychiatric Services. 58(1). 11–11. 18 indexed citations
7.
Citrome, Leslie, et al.. (2006). Incidence, Prevalence, and Surveillance for Diabetes in New York State Psychiatric Hospitals, 1997-2004. Psychiatric Services. 57(8). 1132–1139. 14 indexed citations
8.
Citrome, Leslie, Ari Jaffe, Jerome Levine, & Jean‐Pierre Lindenmayer. (2005). Dosing of Quetiapine in Schizophrenia. The Journal of Clinical Psychiatry. 66(12). 1512–1516. 43 indexed citations
9.
10.
Citrome, Leslie, Ari Jaffe, Jerome Levine, Baerbel Allingham, & J. E. M. Robinson. (2004). Relationship Between Antipsychotic Medication Treatment and New Cases of Diabetes Among Psychiatric Inpatients. Psychiatric Services. 55(9). 1006–1013. 86 indexed citations
11.
Greenhill, Laurence L., Benedetto Vitiello, Prudence W. Fisher, et al.. (2004). Comparison of Increasingly Detailed Elicitation Methods for the Assessment of Adverse Events in Pediatric Psychopharmacology. Journal of the American Academy of Child & Adolescent Psychiatry. 43(12). 1488–1496. 76 indexed citations
12.
Greenhill, Laurence L., Mark Davies, Prudence W. Fisher, et al.. (2003). Developing Methodologies for Monitoring Long-Term Safety of Psychotropic Medications in Children: Report on the NIMH Conference, September 25, 2000. Journal of the American Academy of Child & Adolescent Psychiatry. 42(6). 651–655. 30 indexed citations
13.
Vitiello, Benedetto, Mark A. Riddle, Michael J. Labellarte, et al.. (2003). How Can We Improve the Assessment of Safety in Child and Adolescent Psychopharmacology?. Journal of the American Academy of Child & Adolescent Psychiatry. 42(6). 634–641. 43 indexed citations
14.
Javitt, Daniel C., Angel Cienfuegos, Mario Miniati, et al.. (2002). A Naturalistic Study of Risperidone Treatment Outcome Using Prognosis-Adjusted Discharge Rates in New York State Inpatients. The Journal of Clinical Psychiatry. 63(7). 585–590. 4 indexed citations
15.
Jaffe, Ari & Jerome Levine. (2002). Antipsychotic medication coprescribing in a large state hospital system. Pharmacoepidemiology and Drug Safety. 12(1). 41–48. 76 indexed citations
16.
Citrome, Leslie, Jerome Levine, & Baerbel Allingham. (2000). Changes in Use of Valproate and Other Mood Stabilizers for Patients With Schizophrenia From 1994 to 1998. Psychiatric Services. 51(5). 634–638. 63 indexed citations
17.
Citrome, Leslie, Jerome Levine, & Baerbel Allingham. (1998). Utilization of Valproate: Extent of Inpatient Use in the New York State Office of Mental Health. Psychiatric Quarterly. 69(4). 283–300. 39 indexed citations
18.
Buchanan, Robert W., Brian Kirkpatrick, Ann Summerfelt, et al.. (1992). Clinical predictors of relapse following neuroleptic withdrawal. Biological Psychiatry. 32(1). 72–78. 36 indexed citations
19.
Balter, Mitchell B., Jerome Levine, & Dean I. Manheimer. (1974). Cross-National Study of the Extent of Anti-Anxiety/Sedative Drug Use. New England Journal of Medicine. 290(14). 769–774. 164 indexed citations
20.
Ludwig, Arnold M., et al.. (1970). LSD and alcoholism : a clinical study of treatment efficacy. Thomas eBooks. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cesario Bellantuono Breakdown of academic impact, for papers by R R Fieve Breakdown of academic impact, for papers by Michael D. Jibson Breakdown of academic impact, for papers by Albert A. Kurland Breakdown of academic impact, for papers by Dan Zimbroff Breakdown of academic impact, for papers by Thomas Shiovitz Breakdown of academic impact, for papers by Gilbert Honigfeld Breakdown of academic impact, for papers by Joseph DeVeaugh-Geiss Breakdown of academic impact, for papers by K. Behnke Breakdown of academic impact, for papers by Glen L. Stimmel
Rankless by CCL
2026